Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Mink Therapeutics, Inc. on June 12, 2024. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in New York, New York.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
A total of 28,359,271 shares, representing 81.71% of eligible shares, were present or represented by proxy, constituting a quorum. Stockholders voted on two proposals:
- Proposal 1 (Director Election): Stockholders elected Brian Corvese and Peter Behner as Class III directors for three-year terms expiring in 2027.
- Brian Corvese: 24,620,089 votes For; 0 Against; 374,259 Withheld; 3,364,923 Broker Non-Votes.
- Peter Behner: 24,699,681 votes For; 0 Against; 294,667 Withheld; 3,364,923 Broker Non-Votes.
- Proposal 2 (Auditor Ratification): Stockholders approved the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- Vote Tally: 28,242,636 votes For; 110,437 Against; 6,198 Withheld.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document serves solely to disclose the results of the shareholder vote.
Investor Verification Checklist
- Verify the terms of office for the newly elected Class III directors (Brian Corvese and Peter Behner) expire at the 2027 Annual Meeting.
- Confirm the appointment of KPMG LLP as the independent auditor for the fiscal year ending December 31, 2024.
- Review the Definitive Proxy Statement filed on April 29, 2024, for detailed background on the director nominees and auditor selection.
- Note that approximately 3.36 million shares were broker non-votes on the director election, indicating brokers did not have discretionary authority to vote on these matters.